Cambridge Investment Research Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Buy |
12,082
+3,017
| +33% | +$77.9K | ﹤0.01% | 2945 |
|
|
2025
Q1 | $92K | Buy |
9,065
+615
| +7% | +$6.24K | ﹤0.01% | 3358 |
|
|
2024
Q4 | $118K | Sell |
8,450
-362
| -4% | -$5.06K | ﹤0.01% | 3307 |
|
|
2024
Q3 | $172K | Buy |
8,812
+620
| +8% | +$12.1K | ﹤0.01% | 3191 |
|
|
2024
Q2 | $152K | Sell |
8,192
-209
| -2% | -$3.88K | ﹤0.01% | 3102 |
|
|
2024
Q1 | $118K | Sell |
8,401
-260
| -3% | -$3.65K | ﹤0.01% | 3133 |
|
|
2023
Q4 | $73K | Sell |
8,661
-318
| -4% | -$2.68K | ﹤0.01% | 3070 |
|
|
2023
Q3 | $80K | Sell |
8,979
-151
| -2% | -$1.35K | ﹤0.01% | 2992 |
|
|
2023
Q2 | $79K | Sell |
9,130
-14
| -0.2% | -$121 | ﹤0.01% | 3039 |
|
|
2023
Q1 | $96K | Buy |
9,144
+329
| +4% | +$3.45K | ﹤0.01% | 2970 |
|
|
2022
Q4 | $299K | Buy |
+8,815
| New | +$299K | ﹤0.01% | 2432 |
|
|
2021
Q3 | – | Sell |
-686
| Closed | -$177K | – | 3160 |
|
|
2021
Q2 | $177K | Sell |
686
-2
| -0.3% | -$516 | ﹤0.01% | 2869 |
|
|
2021
Q1 | $206K | Sell |
688
-29
| -4% | -$8.68K | ﹤0.01% | 2598 |
|
|
2020
Q4 | $183K | Sell |
717
-74
| -9% | -$18.9K | ﹤0.01% | 2500 |
|
|
2020
Q3 | $197K | Buy |
791
+1
| +0.1% | +$249 | ﹤0.01% | 2241 |
|
|
2020
Q2 | $275K | Sell |
790
-60
| -7% | -$20.9K | ﹤0.01% | 1951 |
|
|
2020
Q1 | $227K | Sell |
850
-37
| -4% | -$9.88K | ﹤0.01% | 1850 |
|
|
2019
Q4 | $287K | Sell |
887
-89
| -9% | -$28.8K | ﹤0.01% | 1937 |
|
|
2019
Q3 | $267K | Buy |
976
+8
| +0.8% | +$2.19K | ﹤0.01% | 1910 |
|
|
2019
Q2 | $517K | Buy |
968
+81
| +9% | +$43.3K | ﹤0.01% | 1401 |
|
|
2019
Q1 | $447K | Buy |
887
+184
| +26% | +$92.7K | ﹤0.01% | 1565 |
|
|
2018
Q4 | $347K | Sell |
703
-89
| -11% | -$43.9K | ﹤0.01% | 1563 |
|
|
2018
Q3 | $724K | Buy |
792
+473
| +148% | +$432K | 0.01% | 1225 |
|
|
2018
Q2 | $234K | Buy |
319
+68
| +27% | +$49.9K | ﹤0.01% | 1900 |
|
|
2018
Q1 | $400K | Buy |
251
+7
| +3% | +$11.2K | ﹤0.01% | 1468 |
|
|
2017
Q4 | $219K | Buy |
+244
| New | +$219K | ﹤0.01% | 1866 |
|